Results 151 to 160 of about 210,319 (212)

Model-based economic evaluation of pharmacopuncture for chronic low back pain: a 3-year Markov analysis. [PDF]

Front Public Health
Lee YS, Kim S, Ha IH, Lee YJ.
europepmc   +1 more source

Cost-effectiveness analysis of tuberculosis screening in diabetic patients in China: a decision-analytic Markov model. [PDF]

Front Public Health
Song HW, Lin Y, Wan TE, Zhang CF, Pan JS.   +4 more
europepmc   +1 more source

Cost-utility Analysis of R-CHOP vs CHOP in Patients with Non-Hodgkin's Lymphoma: A Systematic Review. [PDF]

Acta Med Philipp
Cadag CFT, Lorenzo AB, Mercado JMM, Ngo FLU.   +3 more
europepmc   +1 more source

Cadonilimab plus chemotherapy for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in China and the United States: a cost-effectiveness analysis. [PDF]

Ther Adv Med Oncol
Wang J, Ding B, Jing Z, Zhu Y, Gao L, Yao H, Tao T, Li X.   +7 more
europepmc   +1 more source

Cost-effectiveness of cabozantinib versus placebo for advanced neuroendocrine tumors from crossover-adjusted analysis in the United States and China. [PDF]

Sci Rep
Lang W, Huang B, Zhang G, Deng L, Lu H, Lu M, Pan Y.   +6 more
europepmc   +1 more source

Cost-Effectiveness of One-Time Universal Childhood Hepatitis C Screening in the United States. [PDF]

J Pediatric Infect Dis Soc
Frankeberger J, Choz M, Kushner T, Reau N, Ostrer L, Wynn A, Martin NK.   +6 more
europepmc   +1 more source

A cost-effective breast cancer screening strategy for Urban China: Findings from a Shenzhen-based modeling study. [PDF]

PLoS One
Tu C, Zhong Y, Li H, Qi H, Lu Q, He X.
europepmc   +1 more source

Immune checkpoint inhibitor-based first-line therapies for advanced or unresectable hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis. [PDF]

Ther Adv Med Oncol
Qi H, Huang Y, Zhang W, Li J, Wang T, Ying Y, Chen B, Miao F, Li Q.   +8 more
europepmc   +1 more source